Shuttle Pharmaceuticals Completes 1-for-10 Reverse Stock Split
SHPH is trading near its 52-week low of $3.81 (9.7% above the low).
Summary
Shuttle Pharmaceuticals completed a 1-for-10 reverse stock split, effective June 11, 2026, to adjust its share price and maintain Nasdaq listing compliance.
Key Events · Corporate Governance and Compliance · SHPH
-
Reverse Stock Split Executed
The company filed a certificate of amendment to its charter, formally implementing a 1-for-10 reverse stock split.
-
Effective Date
The reverse stock split became effective at the start of trading on June 11, 2026.
-
Impact on Convertible Securities
The split proportionately adjusted the number of shares issuable upon exercise or vesting of outstanding warrants, restricted stock units, and convertible preferred stock, increasing their exercise or conversion prices.
-
No Change to Authorized Shares
The total number of authorized shares of common stock or preferred stock was not changed by the reverse split.
Analysis · SHPH · Life Sciences
Shuttle Pharmaceuticals has formally executed a 1-for-10 reverse stock split, a critical step often undertaken by companies facing potential delisting due to low share price. This action, previously approved by shareholders and announced in news, legally alters the company's share structure and is essential for maintaining its Nasdaq listing, especially given its recent history of going concern warnings and lack of revenue.
At the time of this filing, SHPH was trading at $4.18 on NASDAQ in the Life Sciences sector. The 52-week trading range was $3.81 to $61.93. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.